Genetic modification of endostatin
   
   

Chimeric polypeptides comprising a targeting moiety and an antiangiogeneic polypeptide are provided, as well as methods of using the chimeric polypeptides.

 
Web www.patentalert.com

< Process for the isolation and/or purification of a proteinaceous material

< Methods for the preparation of nanosized material particles

> Liquid droplet aerosols of nanoparticulate drugs

> Cyclic amine derivatives-CCR-3 receptor antagonists
~ 00147